Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-16

Scientific Industries Inc (SCND) Stock Forecast Oct. 16, 2026

Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC

Follow Unlock full AI forecasts
Rating · 90D Neutral Total
90-day forecast Sign up free to reveal
30-day forecast Total
Rank in coverage Middle 30% of 5172 stocks scored
Rank correlation · 90D 0.0% Spearman, 357 dates
Market Cap $8M small-cap · #25 of 25 peers
Summary

Scientific Industries Inc (SCND) stock forecast summary

On Oct. 16, 2026, SCND is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5172 stocks scored that day.

Scientific Industries Inc is a small-cap company with a market capitalization of $8M. It ranks number 25 by market capitalization among the 25 Laboratory Analytical Instruments issuers in our coverage with a current forecast. Its Gross Margin of 11.9% is the lowest of the 19 peers that report one.

For SCND, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 0.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -1.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.0%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, SCND included.

Follow SCND free
Price

SCND price chart and AI forecast

SCND
Cross-section · 2026-10-16

How SCND ranks among 5172 stocks

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals · 2026-06-30

Scientific Industries Inc (SCND) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Laboratory Analytical Instruments peers listed below that report each metric.

Valuation & Market

MetricSCNDIndustry medianRank
Market Cap $8M $465M 25/25
P/B Ratio 1.01x 2.39x 19/23
EPS $-0.08 – –
Book Value/Share $0.68 – –
Revenue/Share $0.25 – –
FCF/Share $-0.39 – –

Profitability & Margins

MetricSCNDIndustry medianRank
ROE -9.2% -17.3% 9/20
ROA -7.3% -12.4% 10/20
ROIC -87.9% -11.0% 18/20
Gross Margin 11.9% 47.5% 19/19
Operating Margin -247.9% -14.3% 18/21
Net Margin -24.6% -24.6% 10/19
EBT Margin -43.0% -12.1% 14/22
Tax Rate -0.3% – –

Financial Health

MetricSCNDIndustry medianRank
Current Ratio 5.07x 3.14x 7/25
Quick Ratio 3.86x 2.06x 8/24
D/E Ratio 0.25x 0.47x 19/24
Financial Leverage 1.25x 1.51x 19/23
Interest Coverage -51.5x -22.1x 16/21
Working Capital $7M $147M 22/25

Cash Flow

MetricSCNDIndustry medianRank
Operating Cash Flow -$5M $290K 15/24
Free Cash Flow -$5M -$105K 13/20
Capital Spending -$40K -$5M 1/20
FCF/Sales -153.7% 1.0% 17/19
CapEx/Sales 1.5% 2.7% 14/19

Operational Efficiency

MetricSCNDIndustry medianRank
Asset Turnover 0.30x 0.55x 15/20
Receivables Turnover 5.8x 5.9x 12/19
Inventory Turnover 1.4x 1.9x 17/19
Fixed Assets Turnover 5.0x 5.0x 11/21
Days Sales Outstanding 63 days 62 days 8/19
Days Inventory 267 days 193 days 3/19
Payables Period 72 days 49 days 3/18
Cash Conversion Cycle 257 days 191 days 2/17

Income Statement

MetricSCNDIndustry medianRank
Total Revenue $3M $159M 20/21
Operating Income -$7M -$31M 9/21
Net Income -$740K -$35M 7/21
R&D Expense $3M $38M 20/21
SG&A Expense $5M $145M 20/20
Cost of Goods Sold $3M $97M 18/19

Dividend & Shareholder Information

MetricSCNDIndustry medianRank
Shares Outstanding 12M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$8M80.4% of assets
Cash & Short-term Investments$620K6.1% of assets
Accounts Receivable$520K5.1% of assets
Inventory$2M19.2% of assets
Total Liabilities$2M20.1% of assets
Short-term Debt$1M10.7% of assets
Quarterly Financial Reports

SCND quarterly financials and insider trading

Industry Peers · Laboratory Analytical Instruments

Scientific Industries Inc (SCND) industry peers

Companies classified under the same SEC industry code as Scientific Industries Inc (Laboratory Analytical Instruments): 25 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Total) Market Cap P/E Ratio P/B Ratio
SCND Scientific Industries Inc ▶ $8M – 1.0x
A Agilent Technologies, Inc. ▼ $48.75B 34.0x 6.6x
WAT Waters Corp /De/ ▶ $42.93B 89.7x 2.8x
ILMN Illumina, Inc. ▲ $39.64B 49.4x 14.0x
MTD Mettler Toledo International Inc/ ▼ $32.51B 36.6x –
RVTY Revvity, Inc. ▶ $17.03B 73.4x 2.4x
AVTR Avantor, Inc. ▼ $11.19B – 2.0x
BIO Bio-Rad Laboratories, Inc. ▼ $9.46B 43.2x 1.3x
TXG 10x Genomics, Inc. ▲ $9.10B – 11.0x
BRKR Bruker Corp ▲ $8.35B – 3.5x
ALMR Alamar Biosciences, Inc. ▲ $1.75B – 5.6x
CTKB Cytek Biosciences, Inc. ▲ $682M – 2.1x
PACB Pacific Biosciences Of California, Inc. ▲ $538M – –
MASS 908 Devices Inc. ▲ $465M – 3.7x
NAUT Nautilus Biotechnology, Inc. ▲ $262M – 2.0x
EYPT Eyepoint, Inc. ▲ $258M – 1.6x
BFNH Bioforce Nanosciences Holdings, Inc. ▼ $235M 699.0x 101.8x
QTRX Quanterix Corp ▲ $136M – 0.6x
SEER Seer, Inc. ▲ $113M – 0.3x
RPID Rapid Micro Biosystems, Inc. ▲ $42M – 2.4x
PRPO Precipio, Inc. ▶ $38M – 2.6x
HBIO Harvard Bioscience Inc ▼ $38M – 5.1x
BNGO Bionano Genomics, Inc. ▲ $15M – 0.5x
LCTC Lifeloc Technologies, Inc ▲ $11M – 2.9x
ASTC Astrotech Corp ▶ $10M – 0.6x

Where SCND sits on the market map

Industrial Applications and Services · Laboratory Analytical Instruments
Explore the map →
News

Scientific Industries Inc (SCND) stock news

Loading...

FAQ

Scientific Industries Inc (SCND) stock forecast FAQ

What is the Scientific Industries Inc (SCND) stock forecast?

On Oct. 16, 2026, SCND is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5172 stocks scored that day.

How accurate are Scientific Industries Inc stock predictions?

For SCND, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 0.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -1.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Scientific Industries Inc forecasts updated?

Scientific Industries Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.

Which companies are Scientific Industries Inc's industry peers?

25 issuers in our coverage, SCND included, share the SEC industry code Laboratory Analytical Instruments. The largest are: Agilent Technologies, Inc. (A), Waters Corp /De/ (WAT), Illumina, Inc. (ILMN), Mettler Toledo International Inc/ (MTD), Revvity, Inc. (RVTY), Avantor, Inc. (AVTR).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.